← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 GRAIL Inc GRAL $6.05B	–	–	–	–
102	GRCL 102 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
103	GRML 103 Greenland Mines Ltd GRML $92.9M	–	–	–	–
104	GTH 104 DELISTED Genetron Holdings Limited ADS GTH	–	–	–	–
105	105 Fractyl Health GUTS $55.2M	–	–	–	–
106	106 Franklin Genomic Advancements ETF HELX $29.8M	–	–	–	–
107	HTGM 107 DELISTED HTG Molecular Diagnostics, Inc. Common Stock HTGM	–	–	–	–
108	108 iShares Genomics Immunology and Healthcare ETF IDNA $317M	–	–	–	–
109	109 Immix Biopharma IMMX $720M	–	–	–	–
110	110 Immatics IMTX $1.09B	–	–	–	–
111	111 IN8bio INAB $11.7M	–	–	–	–
112	112 MiNK Therapeutics INKT $50.7M	–	–	–	–
113	113 INmune Bio INMB $45.8M	–	–	–	–
114	114 Century Therapeutics IPSC $272M	–	–	–	–
115	ISEE 115 DELISTED IVERIC bio, Inc. Common Stock ISEE	–	–	–	–
116	KRBP 116 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–
117	117 Korro Bio KRRO $137M	–	–	–	–
118	118 Krystal Biotech KRYS $9.77B	–	–	–	–
119	119 Kyverna Therapeutics KYTX $369M	–	–	–	–
120	120 Legend Biotech LEGN $3.85B	–	–	–	–
121	LGVN 121 Longeveron LGVN $4.78M	–	–	–	–
122	122 Lakefront Biotherapeutics American Depositary Shares LKFT $1.96B	–	–	–	–
123	123 Lunai Bioworks LNAI $3.74M	–	–	–	–
124	LOGC 124 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	–	–	–	–
125	125 Lexeo Therapeutics LXEO $227M	–	–	–	–